ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,882Medicare Part D Prescriptions Filled, Including Refills

Rank: 172 out of 2343

$947K Total Retail Price of All Prescriptions

Rank: 150 out of 2343

467 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 467 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 13,519 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 648 586 1 1
METOPROLOL TARTRATE 628 579 2 7
LEVOTHYROXINE SODIUM 546 501 3 2
WARFARIN SODIUM 479 363 4 8
FUROSEMIDE 477 413 5 6
LISINOPRIL 456 413 6 3
OMEPRAZOLE 396 364 7 4
SERTRALINE HCL 373 314 8 20
HYDROCODONE-ACETAMINOPHEN 370 213 S3 9 13
HYDROCHLOROTHIAZIDE 361 359 10 11
METOPROLOL SUCCINATE 352 338 11 14
AMLODIPINE BESYLATE 340 315 12 5
PREDNISONE 331 307 13 37
METFORMIN HCL 220 198 14 9
ATORVASTATIN CALCIUM 207 179 15 10
GABAPENTIN 200 125 16 16
PANTOPRAZOLE SODIUM 190 143 17 22
DIOVAN 181 150 18 23
CLOPIDOGREL 180 146 19 26
GLIPIZIDE 177 169 20 56
DONEPEZIL HCL 174 169 21 21
ATENOLOL 169 169 22 12
ZOLPIDEM TARTRATE 169 101 22 24
JANUVIA 165 143 24 50
SPIRONOLACTONE 157 110 25 65
DIGOXIN 135 100 26 35
TAMSULOSIN HCL 128 121 27 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 96 28 42
NEXIUM 125 122 28 33
TRAMADOL HCL 124 110 30 25
PLAVIX 122 99 31 38
PRAVASTATIN SODIUM 117 101 32 15
LANTUS 116 53 33 51
CIPROFLOXACIN HCL 114 103 34 72
KLOR-CON M20 107 81 35 44
DIOVAN HCT 103 99 36 63
FAMOTIDINE 97 71 37 60
ENALAPRIL MALEATE 97 89 37 58
FENTANYL 95 73 S2 39 69
CLONIDINE HCL 92 88 40 70
OXYCODONE-ACETAMINOPHEN 91 76 S2 41 49
AMLODIPINE BESYLATE-BENAZEPRIL 90 90 42 59
TRICOR 88 88 43 96
AZITHROMYCIN 88 78 43 39
AMITRIPTYLINE HCL 87 52 R 45 117
LYRICA 85 57 46 135
NAMENDA 84 84 47 36
ISOSORBIDE MONONITRATE ER 81 65 48 32
SPIRIVA 79 68 49 48
CRESTOR 78 78 50 30
ALLOPURINOL 76 74 51 31
QUETIAPINE FUMARATE 75 71 52 77
AMOXICILLIN 72 66 53 118
ALBUTEROL SULFATE 72 71 53 126
FENOFIBRATE 72 68 53 94
ADVAIR DISKUS 71 70 56 34
PAROXETINE HCL 70 68 57 66
VERAPAMIL ER 69 65 58 95
CARVEDILOL 69 56 58 27
LIPITOR 67 53 60 78
FLUTICASONE PROPIONATE 66 57 61 46
NAPROXEN 65 55 62 108
CELEBREX 64 59 63 71
NITROSTAT 62 50 64 164
POTASSIUM CHLORIDE 61 61 65 18
DILTIAZEM 24HR CD 60 60 66 83
PEN NEEDLE 59 33 67 119
FOSINOPRIL SODIUM 58 58 68 332
DICLOFENAC SODIUM 58 48 68 155
METHOTREXATE 58 55 68 235
ONGLYZA 55 39 71 211
PRIMIDONE 54 54 72 318
SYNTHROID 54 50 72 40
ZETIA 52 36 74 52
EXFORGE 52 52 74 163
NOVOLOG MIX 70-30 51 51 76 257
REBIF 50 0 77 489
VENLAFAXINE HCL ER 50 41 77 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.